Salix Pharmaceuticals, Ltd. news

   Watch this stock
Showing stories 1 - 10 of about 102   

Articles published

SLXP 172.60 -0.03 (-0.02%)
price chart
Valeant Pharmaceuticals Teams Up With Ackman As The Salix Pharmaceuticals ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) will be sweetening its acquisition offer for Salix Pharmaceuticals, Ltd.
Salix Pharmaceuticals (SLXP) Stock Closed Lower Today as Valeant Looks to ...  TheStreet.com
Salix Pharmaceuticals, Ltd. Confirms Receipt of an Unsolicited Proposal from ...  Yahoo Finance UK
Why Salix Pharmaceuticals, Ltd. Stock Was Clobbered in November
What: Shares of Salix Pharmaceuticals (NASDAQ: SLXP ) , a biopharmaceutical company that develops and acquires drugs designed to treat gastrointestinal diseases, was clobbered in November and fell by 29%, based on data from S&P Capital IQ, after the ...
Related articles »  
Here's Why Salix Pharmaceuticals, Ltd. Executives Received Millions Even After ...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) has paid as much as $46 million combined to two of the top executives who left the company following the accounting scandal late last year.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) close to 52-week high on important ...  Markets Wired
Benzinga's Top Downgrades  Benzinga
Stock Analysis on Salix Pharmaceuticals Ltd. (NASDAQ:SLXP)
[Bloomberg] Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)(TREND ANALYSIS), Two top executives at Salix Pharmaceuticals Ltd. who left after accounting errors at the company will walk away with a combined $46 million, following the company's sale to ...
What to Expect When Salix Pharmaceuticals (SLXP) Reports Fourth Quarter ...
SALIX PHARMACEUTICALS LTD has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Salix Pharmaceuticals, Ltd. (SLXP) Q4 Revenue Hits A Record Low  Bidness ETC
Salix Pharmaceuticals Reports 4Q2014 and FY2014 Results  MarketWatch
Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) a Hold: Jefferies
In a research note issued to investors, David Steinberg at Jefferies Downgraded their rating on Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) to a Hold. The analyst placed a $173.00 price target on the stock which indicates a 0.23% upside to the last ...
Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma ...
On Wednesday, shares in Salix Pharmaceuticals Ltd recorded a trading volume of 1.15 million shares, lower than its three months average volume of 3.31 million shares.
Endo International plc May Hunt Smaller Targets After Losing Salix ...
Endo International Plc (NASDAQ:ENDP) withdrew its $11 billion cash-and-stock offer to acquire Salix Pharmaceuticals Ltd. (NASDAQ:SLXP), as Valeant Pharmaceuticals International Inc. (NYSE:VRX) won the bid with a higher offer.
Valeant Wins Battle for Salix Pharmaceuticals  Wall Street Journal
Valeant Inc lands Salix Ltd with knockout bid, but forced to pay more than ...  Financial Post
Salix Pharmaceuticals (SLXP) Stock Surges Today After Endo Makes $11 Billion ...
SALIX PHARMACEUTICALS LTD has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Endo International plc - Ordinary Shares Tries To Woo Salix Pharmaceuticals ...  Bidness ETC
Surprise Rival Bid Emerges for Salix  Wall Street Journal
Tuesday's Vital Data: Netflix, Inc. (NFLX), Alibaba Group Holding Ltd (BABA ...
Salix Pharmaceuticals Ltd. (SLXP). Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fired another shot in the bidding war for Salix Pharmaceuticals this week, boosting its bid for the company to $173 per share, or $11.1 billion, in an all cash deal.